Under the federal government's Hill-Burton program[14] low-income patients may qualify for free or low-cost services. Shopping for lung cancer treatment: Nineteen states and the District of Columbia have enacted oral chemotherapy access laws[15] that require private health plans to cover cancer ...
Cost-components of lung cancer care within the first three years after initial diagnosis in context of different treatment regimens. Lung Cancer, 2015, 90(2): 274-280.Schwarzkopf L, Wacker M, Holle R, Leidl R, Gunster C, Adler JB, et al. Cost-components of lung cancer care within the ...
Racial‐ethnic disparity • Lung cancer • End‐of‐life care • Cost and utilizationThe end‐of‐life period is a crucial time in lung cancer care. To have a better understanding of the racial‐ethnic disparities in health care expenditures, access, and quality, we evaluated these ...
- 《Bmc Health Services Research》 被引量: 40发表: 2001年 Cancer Patient Care in Clinical Trials Sponsored by the National Cancer Institute: What Does It Cost? Discusses the financial coverage of patient care for patient's enrolled in clinical trials in the United States. Reason the financial ...
Clinical trials offer innovative therapeutic options with potentially better outcomes, but their effects on health care costs are disputed.METHODSThe authors analyzed the 1-year facility-based treatment cost and survival of 336 newly diagnosed nonsmall cell lung cancer patients who were deemed eligible ...
Parameters come from the China Lung Cancer Screening Project, cancer registry data, etc. The Incremental Cost-effectiveness Ratio (ICER) between screening and non-screening strategies at the same initial age is evaluated. ...
Aim: To evaluate the cost utility and budget impact of second-line gefitinib for non-small cell lung cancer from a Thai payer perspective.Methods: A Markov... S Thongprasert,S Tinmanee,U Permsuwan - Asia-Pacific Journal of Clinical Oncology 被引量: 25发表: 2012年 Quality-of-life and ...
We found that unless screen participation increases smoking cessation, lung cancer screening was considerably more expensive than other U.S. screening programs. Colorectal cancer screening—widely viewed to be cost-effective—has cost-effectiveness ratios (versus no screening) in the range of $13,000...
Second- line treatment for advanced-stage non-small-cell lung cancer: current and future options. Clin Lung Cancer 2006; 7(Suppl 4):S118-25; PMID:... C Ho,AM Davies,JPN Lara,... - 《Clinical Lung Cancer》 被引量: 164发表: 2006年 Clinical and cost effectiveness of paclitaxel, docetax...
of 1% increasing of effectiveness rate was 10.5 yuan(RMB);The effectiveness rate of GP was 85.7%,the cost of GP was 12 372.04 yuan(RMB),the cost of 1% increasing of effectiveness rate was 144.36 yuan(RMB).Conclusion PE is the most reasonable chemotherapy scheme for small cell lung cancer....